Concord Medical Services Holdings Ltd
No enriched coverage for $CCM in the last 7 days.
No SEC Form 4 filings for $CCM in the last 30 days.
See all $CCM insider activity →Two Harbors Investment Corp. (TWO) received final regulatory approval for its merger with CrossCountry Mortgage (CCM). The deal, expected to close by Aug. 25, will give TWO shareholders $12 per share and a prorated dividend. TWO faces a $500M+ lawsuit from UWM over the merger.
CCM’s parent plans to sell $750M in senior unsecured notes to refinance its MSR credit line tied to the $1.26B Two Harbors transaction. Fitch expects a BB-(EXP) rating and says proceeds would repay MSR-backed facilities. The deal would add a $159B servicing portfolio to CCM’s $202B book, moving it to No. 8. Fitch projects corporate leverage rising to 2.4x, with leverage reduction needed to avoid downgrade.
Fitch said CCM’s leverage may rise temporarily as it issues $500M in debt to fund its near-closing $1.26B deal to buy Two Harbors. The combined servicing portfolio would total $159B plus CCM’s $202B (Q1). Fitch noted a shift to unsecured debt could support liquidity, while ratings depend on reducing leverage toward 1.0x.
Recent CCM coverage spans financial news, mergers & acquisitions and corporate actions.
Merger approval confirms CCM will be absorbed, likely driving its price toward the agreed $12 per share consideration.
Unsecured note issuance to repay MSR credit lines should support liquidity and reduce collateral constraints, but leverage is expected to rise post-acquisition.
Debt issuance and deal closing are credit-relevant, with Fitch warning ratings could be pressured if leverage does not fall to 1.5x or below.
The transaction expands CCM’s servicing footprint and aims to create an integrated origination-to-servicing platform.
The initial Form 3 filing by director Wayne Yu for Concord Medical (CCM) indicates no immediate insider trading activity or share changes, suggesting a neutral short-term impact.
alphai scores every news story that mentions CCM with an AI model for sentiment and relevance, and aggregates insider trades from Concord Medical Services Holdings Ltd's SEC EDGAR Form 4 filings. Figures refresh continuously.
Two Harbors Investment Corp. (TWO) received final regulatory approval for its merger with CrossCountry Mortgage (CCM). The deal, expected to close by Aug. 25, will give TWO shareholders $12 per share and a prorated dividend. TWO faces a $500M+ lawsuit from UWM over the merger.
2 min readCCM’s parent plans to sell $750M in senior unsecured notes to refinance its MSR credit line tied to the $1.26B Two Harbors transaction. Fitch expects a BB-(EXP) rating and says proceeds would repay MSR-backed facilities. The deal would add a $159B servicing portfolio to CCM’s $202B book, moving it to No. 8. Fitch projects corporate leverage rising to 2.4x, with leverage reduction needed to avoid downgrade.
4 min readFitch said CCM’s leverage may rise temporarily as it issues $500M in debt to fund its near-closing $1.26B deal to buy Two Harbors. The combined servicing portfolio would total $159B plus CCM’s $202B (Q1). Fitch noted a shift to unsecured debt could support liquidity, while ratings depend on reducing leverage toward 1.0x.
6 min readMortgage rates edged up on renewed U.S.-Iran war risks, while applications were largely unchanged. Two Harbors (TWO) shareholders approved its acquisition by CrossCountry Mortgage (CCM) for $12/share cash plus a stub dividend, pending election certification. ICE reported delinquencies rose to 3.5% due to a calendar effect. MBA said housing supply may outpace demand in early 2030s.
5 min readConcord Medical Services Holdings Ltd director Wayne Yu has filed an initial Form 3 report, indicating his position as a director of the company. This filing does not report any insider transactions or changes in share ownership, signifying a neutral impact and sentiment. The document details the beneficial ownership statement required by the SEC.
1 min readConcord Medical Services Holdings Ltd's CFO, Jiang Wei, has filed an initial Form 3, establishing him as a reporting person for the company's securities. This filing indicates that Jiang Wei is now subject to insider reporting rules, but it does not show any buy, sell, or derivative transactions at this time. The Form 3 formally records his obligation to report future changes in his Concord Medical securities holdings.
2 min readRESTON, Va., Aug. 28, 2025 /PRNewswire/ -- The National Contract Management Association ( NCMA ) and the Commerce & Contract Management Institute ( CCM Institute ) are pleased to announce that on 1 September, Dr. Daniel J. Finkenstadt will join its leadership team as Vice President of Research ...
2 min readU.S. stocks were lower, with the Dow Jones index falling around 200 points on Wednesday. Shares of Western Digital Corporation WDC rose sharply during Wednesday's session after the company reported better-than-expected third-quarter adjusted EPS results and issued fourth-quarter adjusted EPS ...
3 min read
